Cited by 22Advanced Proteomics Techniques and ApplicationsGut microbiota and healthGenomics and Phylogenetic Studies

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Metaproteomics in the One Health framework for unraveling microbial effectors in microbiomes

Open access

Published version of a preprint

Abstract

One Health seeks to integrate and balance the health of humans, animals, and environmental systems, which are intricately linked through microbiomes. These microbial communities exchange microbes and genes, influencing not only human and animal health but also key environmental, agricultural, and biotechnological processes. Preventing the emergence of pathogens as well as monitoring and controlling the composition of microbiomes through microbial effectors including virulence factors, toxins, antibiotics, non-ribosomal peptides, and viruses holds transformative potential. However, the mechanisms by which these microbial effectors shape microbiomes and their broader functional consequences for host and ecosystem health remain poorly understood. Metaproteomics offers a novel methodological framework as it provides insights into microbial dynamics by quantifying microbial biomass composition, metabolic functions, and detecting effectors like viruses, antimicrobial resistance proteins, and non-ribosomal peptides. Here, we highlight the potential of metaproteomics in elucidating microbial effectors and their impact on microbiomes and discuss their potential for modulating microbiomes to foster desired functions. Graphical Abstract Word Cloud showing the abundance of keywords in combination with the “Microbiome” in PubMed NCBI. As abundance values, the rounded logarithm with the base of 2 hits were used and submitted to https://wordart.com/create . For microbiome, the number without any combination was used for calculation. The word cloud displays different aspects of microbiome research: (i.) sources of microbiomes (green), (ii.) interactions (purple), (iii.) involved taxa (red), (iv.) applied experimental approaches (blue), and (vi.) societal effects and recent or future applications (gray).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s40168-025-02119-5

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 156

  1. Naghavi M, Vollset SE, Ikuta KS, Swetschinski LR, Gray AP, Wool EE, et al. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. Lancet. 2024;404:1199–226. https://doi.org/10.1016/S0140-6736(24)01867-1. · DOI · Paper page
  2. Joerger RD. Alternatives to antibiotics: bacteriocins, antimicrobial peptides and bacteriophages. Poult Sci. 2003;82:640–7. https://doi.org/10.1093/ps/82.4.640. · DOI
  3. Cycoń M. Mrozik a, piotrowska-seget z. antibiotics in the soil environment-degradation and their impact on microbial activity and diversity. Front Microbiol. 2019;10:338. https://doi.org/10.3389/fmicb.2019.00338. · DOI
  4. Wilmes P, Bond PL. The application of two-dimensional polyacrylamide gel electrophoresis and downstream analyses to a mixed community of prokaryotic microorganisms. Environ Microbiol. 2004;6:911–20. https://doi.org/10.1111/j.1462-2920.2004.00687.x. · DOI
  5. Pérez-Cobas AE, Gosalbes MJ, Friedrichs A, Knecht H, Artacho A, Eismann K, et al. Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. Gut. 2013;62:1591–601. https://doi.org/10.1136/gutjnl-2012-303184. · DOI
  6. Buthasane P, Roytrakul S, Phaonakrop N, Tunsagool P, Buthasane W, Am-In N, Suriyaphol G. Metaproteomic analysis of gut resistome in the cecal microbiota of fattening pigs raised without antibiotics. Microbiol Spectr. 2023;11: e0222323. https://doi.org/10.1128/spectrum.02223-23. · DOI
  7. Zhang L, Li L, Sha G, Liu C, Wang Z, Wang L. Aerobic composting as an effective cow manure management strategy for reducing the dissemination of antibiotic resistance genes: an integrated meta-omics study. J Hazard Mater. 2020;386: 121895. https://doi.org/10.1016/j.jhazmat.2019.121895. · DOI
  8. Saenz JS, Kurz A, Ruczizka U, Bünger M, Dippel M, Nagl V, et al. Metaproteomics reveals alteration of the gut microbiome in weaned piglets due to the ingestion of the mycotoxins deoxynivalenol and zearalenone. Toxins (Basel). 2021. https://doi.org/10.3390/toxins13080583. · DOI
  9. Peters SL, Borges AL, Giannone RJ, Morowitz MJ, Banfield JF, Hettich RL. Experimental validation that human microbiome phages use alternative genetic coding. Nat Commun. 2022;13:5710. https://doi.org/10.1038/s41467-022-32979-6. · DOI
  10. Lozano C, Pible O, Eschlimann M, Giraud M, Debroas S, Gaillard J-C, et al. Universal identification of pathogenic viruses by liquid chromatography coupled with tandem mass spectrometry proteotyping. Mol Cell Proteomics. 2024;23: 100822. https://doi.org/10.1016/j.mcpro.2024.100822. · DOI
  11. Heyer R, Schallert K, Siewert C, Kohrs F, Greve J, Maus I, et al. Metaproteome analysis reveals that syntrophy, competition, and phage-host interaction shape microbial communities in biogas plants. Microbiome. 2019;7:69. https://doi.org/10.1186/s40168-019-0673-y. · DOI
  12. Zhou S, Liu B, Zheng D, Chen L, Yang J. VFDB 2025: an integrated resource for exploring anti-virulence compounds. Nucleic Acids Res. 2025;53:D871–7. https://doi.org/10.1093/nar/gkae968. · DOI
  13. Sunyer JO, Delgado LF, Hickl O, Laczny CC, May P, Wilmes P. PathoFact 2.0: an integrative pipeline for predicting antimicrobial resistance genes, virulence factors, toxins and biosynthetic gene clusters in metagenomes 2024. https://doi.org/10.1101/2024.12.09.627531. · DOI
  14. Dong W, Fan X, Guo Y, Wang S, Jia S, Lv N, et al. An expanded database and analytical toolkit for identifying bacterial virulence factors and their associations with chronic diseases. Nat Commun. 2024;15:8084. https://doi.org/10.1038/s41467-024-51864-y. · DOI
  15. Danov A, Segev O, Bograd A, Ben Eliyahu Y, Dotan N, Kaplan T, Levy A. Toxinome-the bacterial protein toxin database. mBio. 2024;15:e0191123. https://doi.org/10.1128/mbio.01911-23. · DOI
  16. Guan J, Chen Y, Goh Y-X, Wang M, Tai C, Deng Z, et al. TADB 3.0: an updated database of bacterial toxin-antitoxin loci and associated mobile genetic elements. Nucleic Acids Res. 2024;52:D784–90. https://doi.org/10.1093/nar/gkad962. · DOI
  17. Farrell LJ, Lo R, Wanford JJ, Jenkins A, Maxwell A, Piddock LJV. Revitalizing the drug pipeline: antibioticDB, an open access database to aid antibacterial research and development. J Antimicrob Chemother. 2018;73:2284–97. https://doi.org/10.1093/jac/dky208. · DOI
  18. Knox C, Wilson M, Klinger CM, Franklin M, Oler E, Wilson A, et al. DrugBank 6.0: the DrugBank Knowledgebase for 2024. Nucleic Acids Res. 2024;52:D1265–75. https://doi.org/10.1093/nar/gkad976. · DOI
  19. Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, et al. The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res. 2024;52:D1180–92. https://doi.org/10.1093/nar/gkad1004. · DOI
  20. Alcock BP, Huynh W, Chalil R, Smith KW, Raphenya AR, Wlodarski MA, et al. CARD 2023: expanded curation, support for machine learning, and resistome prediction at the Comprehensive Antibiotic Resistance Database. Nucleic Acids Res. 2023;51:D690–9. https://doi.org/10.1093/nar/gkac920. · DOI · Paper page
  21. Blin K, Shaw S, Augustijn HE, Reitz ZL, Biermann F, Alanjary M, et al. antiSMASH 7.0: new and improved predictions for detection, regulation, chemical structures and visualisation. Nucleic Acids Res. 2023;51:W46–50. https://doi.org/10.1093/nar/gkad344. · DOI
  22. Florensa AF, Kaas RS, Clausen PTLC, Aytan-Aktug D, Aarestrup FM. ResFinder - an open online resource for identification of antimicrobial resistance genes in next-generation sequencing data and prediction of phenotypes from genotypes. Microb Genom. 2022. https://doi.org/10.1099/mgen.0.000748. · DOI · Paper page
  23. Gawde U, Chakraborty S, Waghu FH, Barai RS, Khanderkar A, Indraguru R, et al. CAMPR4: a database of natural and synthetic antimicrobial peptides. Nucleic Acids Res. 2023;51:D377–83. https://doi.org/10.1093/nar/gkac933. · DOI
  24. Yao L, Guan J, Xie P, Chung C-R, Zhao Z, Dong D, et al. dbAMP 3.0: updated resource of antimicrobial activity and structural annotation of peptides in the post-pandemic era. Nucleic Acids Res. 2025;53:D364–76. https://doi.org/10.1093/nar/gkae1019. · DOI
  25. Pirtskhalava M, Amstrong AA, Grigolava M, Chubinidze M, Alimbarashvili E, Vishnepolsky B, et al. DBAASP v3: database of antimicrobial/cytotoxic activity and structure of peptides as a resource for development of new therapeutics. Nucleic Acids Res. 2021;49:D288–97. https://doi.org/10.1093/nar/gkaa991. · DOI
  26. Ma T, Liu Y, Yu B, Sun X, Yao H, Hao C, et al. DRAMP 4.0: an open-access data repository dedicated to the clinical translation of antimicrobial peptides. Nucleic Acids Res. 2025;53:D403–10. https://doi.org/10.1093/nar/gkae1046. · DOI
  27. Santos-Júnior CD, Pan S, Zhao X-M, Coelho LP. Macrel: antimicrobial peptide screening in genomes and metagenomes. PeerJ. 2020;8: e10555. https://doi.org/10.7717/peerj.10555. · DOI
  28. Gholamizoj S, Ma B. SPEQ: quality assessment of peptide tandem mass spectra with deep learning. Bioinformatics. 2022;38:1568–74. https://doi.org/10.1093/bioinformatics/btab874. · DOI
  29. Lertampaiporn S, Vorapreeda T, Hongsthong A, Thammarongtham C. Ensemble-AMPPred: robust AMP prediction and recognition using the ensemble learning method with a new hybrid feature for differentiating AMPs. Genes (Basel). 2021. https://doi.org/10.3390/genes12020137. · DOI
  30. Yan J, Bhadra P, Li A, Sethiya P, Qin L, Tai HK, et al. Deep-AmPEP30: improve short antimicrobial peptides prediction with deep learning. Mol Ther Nucleic Acids. 2020;20:882–94. https://doi.org/10.1016/j.omtn.2020.05.006. · DOI
  31. Agrawal P, Mohanty D. A machine learning-based method for prediction of macrocyclization patterns of polyketides and non-ribosomal peptides. Bioinformatics. 2021;37:603–11. https://doi.org/10.1093/bioinformatics/btaa851. · DOI
  32. Behsaz B, Bode E, Gurevich A, Shi Y-N, Grundmann F, Acharya D, et al. Integrating genomics and metabolomics for scalable non-ribosomal peptide discovery. Nat Commun. 2021;12:3225. https://doi.org/10.1038/s41467-021-23502-4. · DOI
  33. Pereira-Flores E, Medema M, Buttigieg PL, Meinicke P, Glöckner FO, Fernández-Guerra A. Mining metagenomes for natural product biosynthetic gene clusters: unlocking new potential with ultrafast techniques. 2021. https://doi.org/10.1101/2021.01.20.427441. · DOI
  34. Navarro-Muñoz JC, Selem-Mojica N, Mullowney MW, Kautsar SA, Tryon JH, Parkinson EI, et al. A computational framework to explore large-scale biosynthetic diversity. Nat Chem Biol. 2020;16:60–8. https://doi.org/10.1038/s41589-019-0400-9. · DOI
  35. Ziemert N, Podell S, Penn K, Badger JH, Allen E, Jensen PR. The natural product domain seeker NaPDoS: a phylogeny based bioinformatic tool to classify secondary metabolite gene diversity. PLoS ONE. 2012;7: e34064. https://doi.org/10.1371/journal.pone.0034064. · DOI
  36. Rolland C, Wittmann J, Reimer LC, Sardà Carbasse J, Schober I, Dudek C-A, et al. PhageDive: the comprehensive strain database of prokaryotic viral diversity. Nucleic Acids Res. 2025;53:D819–25. https://doi.org/10.1093/nar/gkae878. · DOI
  37. Camarillo-Guerrero LF, Almeida A, Rangel-Pineros G, Finn RD, Lawley TD. Massive expansion of human gut bacteriophage diversity. Cell. 2021;184:1098-1109.e9. https://doi.org/10.1016/j.cell.2021.01.029. · DOI · Paper page
  38. Gao NL, Zhang C, Zhang Z, Hu S, Lercher MJ, Zhao X-M, et al. MVP: a microbe-phage interaction database. Nucleic Acids Res. 2018;46:D700–7. https://doi.org/10.1093/nar/gkx1124. · DOI
  39. Russell DA, Hatfull GF. PhagesDB: the actinobacteriophage database. Bioinformatics. 2017;33:784–6. https://doi.org/10.1093/bioinformatics/btw711. · DOI
  40. Criel B, Taelman S, van Criekinge W, Stock M, Briers Y. PhaLP: a database for the study of phage lytic proteins and their evolution. Viruses. 2021. https://doi.org/10.3390/v13071240. · DOI
  41. Tynecki P, Guziński A, Kazimierczak J, Jadczuk M, Dastych J, Onisko A. PhageAI - bacteriophage life cycle recognition with machine learning and natural language processing. 2020. https://doi.org/10.1101/2020.07.11.198606. · DOI
  42. Marquet M, Hölzer M, Pletz MW, Viehweger A, Makarewicz O, Ehricht R, Brandt C. What the phage: a scalable workflow for the identification and analysis of phage sequences. Gigascience. 2022. https://doi.org/10.1093/gigascience/giac110. · DOI
  43. Wishart DS, Han S, Saha S, Oler E, Peters H, Grant JR, et al. PHASTEST: faster than PHASTER, better than PHAST. Nucleic Acids Res. 2023;51:W443–50. https://doi.org/10.1093/nar/gkad382. · DOI
  44. Holstein T, Kistner F, Martens L, Muth T. PepGM: a probabilistic graphical model for taxonomic inference of viral proteome samples with associated confidence scores. Bioinformatics. 2023. https://doi.org/10.1093/bioinformatics/btad289. · DOI
  45. Wang W, Ren J, Tang K, Dart E, Ignacio-Espinoza JC, Fuhrman JA, et al. A network-based integrated framework for predicting virus-prokaryote interactions. NAR Genom Bioinform. 2020;2: lqaa044. https://doi.org/10.1093/nargab/lqaa044. · DOI
  46. Graf AC, Striesow J, Pané-Farré J, Sura T, Wurster M, Lalk M, et al. An innovative protocol for metaproteomic analyses of microbial pathogens in cystic fibrosis sputum. Front Cell Infect Microbiol. 2021;11: 724569. https://doi.org/10.3389/fcimb.2021.724569. · DOI
  47. Messer LF, Lee CE, Wattiez R, Matallana-Surget S. Novel functional insights into the microbiome inhabiting marine plastic debris: critical considerations to counteract the challenges of thin biofilms using multi-omics and comparative metaproteomics. Microbiome. 2024;12:36. https://doi.org/10.1186/s40168-024-01751-x. · DOI
  48. Wang D-Z, Gao Y, Lin L, Hong H-S. Comparative proteomic analysis reveals proteins putatively involved in toxin biosynthesis in the marine dinoflagellate Alexandrium catenella. Mar Drugs. 2013;11:213–32. https://doi.org/10.3390/md11010213. · DOI
  49. Barrett TC, Mok WWK, Murawski AM, Brynildsen MP. Enhanced antibiotic resistance development from fluoroquinolone persisters after a single exposure to antibiotic. Nat Commun. 2019;10:1177. https://doi.org/10.1038/s41467-019-09058-4. · DOI
  50. Sidjabat HE, Gien J, Kvaskoff D, Ashman K, Vaswani K, Reed S, et al. The use of SWATH to analyse the dynamic changes of bacterial proteome of carbapanemase-producing Escherichia coli under antibiotic pressure. Sci Rep. 2018;8:3871. https://doi.org/10.1038/s41598-018-21984-9. · DOI
  51. Doron S, Melamed S, Ofir G, Leavitt A, Lopatina A, Keren M, et al. Systematic discovery of anti-phage defense systems in the microbial pan-genome. Science. 2018. https://doi.org/10.1126/science.aar4120. · DOI
  52. Martínez Arbas S, Narayanasamy S, Herold M, Lebrun LA, Hoopmann MR, Li S, et al. Roles of bacteriophages, plasmids and CRISPR immunity in microbial community dynamics revealed using time-series integrated meta-omics. Nat Microbiol. 2021;6:123–35. https://doi.org/10.1038/s41564-020-00794-8. · DOI
  53. Sharma AK, Dhasmana N, Dubey N, Kumar N, Gangwal A, Gupta M, Singh Y. Bacterial virulence factors: secreted for survival. Indian J Microbiol. 2017;57:1–10. https://doi.org/10.1007/s12088-016-0625-1. · DOI
  54. Lee YM, Almqvist F, Hultgren SJ. Targeting virulence for antimicrobial chemotherapy. Curr Opin Pharmacol. 2003;3:513–9. https://doi.org/10.1016/j.coph.2003.04.001. · DOI
  55. Friesen TL, Stukenbrock EH, Liu Z, Meinhardt S, Ling H, Faris JD, et al. Emergence of a new disease as a result of interspecific virulence gene transfer. Nat Genet. 2006;38:953–6. https://doi.org/10.1038/ng1839. · DOI
  56. Gyles C, Boerlin P. Horizontally transferred genetic elements and their role in pathogenesis of bacterial disease. Vet Pathol. 2014;51:328–40. https://doi.org/10.1177/0300985813511131. · DOI
  57. Pérez-Etayo L, González D, Vitas AI. The aquatic ecosystem, a good environment for the horizontal transfer of antimicrobial resistance and virulence-associated factors among extended spectrum β-lactamases producing E. coli. microorganisms 2020. https://doi.org/10.3390/microorganisms8040568. · DOI
  58. Søborg DA, Hendriksen NB, Kilian M, Christensen JH, Kroer N. Bacterial human virulence genes across diverse habitats as assessed by in silico analysis of environmental metagenomes. Front Microbiol. 2016;7: 1712. https://doi.org/10.3389/fmicb.2016.01712. · DOI
  59. Hoorzook KB, Barnard TG. Absolute quantification of E. coli virulence and housekeeping genes to determine pathogen loads in enumerated environmental samples. PLoS One. 2021;16: e0260082. https://doi.org/10.1371/journal.pone.0260082. · DOI
  60. de Nies L, Lopes S, Busi SB, Galata V, Heintz-Buschart A, Laczny CC, et al. PathoFact: a pipeline for the prediction of virulence factors and antimicrobial resistance genes in metagenomic data. Microbiome. 2021;9:49. https://doi.org/10.1186/s40168-020-00993-9. · DOI
  61. Hosseini H, Mahmoudi R, Pakbin B, Manafi L, Hosseini S, Pilevar Z, Brück WM. Effects of intrinsic and extrinsic growth factors on virulence gene expression of foodborne pathogens in vitro and in food model systems; a review. Food Sci Nutr. 2024;12:6093–107. https://doi.org/10.1002/fsn3.4281. · DOI
  62. Penttinen R, Kinnula H, Lipponen A, Bamford JKH, Sundberg L-R. High nutrient concentration can induce virulence factor expression and cause higher virulence in an environmentally transmitted pathogen. Microb Ecol. 2016;72:955–64. https://doi.org/10.1007/s00248-016-0781-1. · DOI
  63. Nwaji AR, Arieri O, Anyang AS, Nguedia K, Abiade EB, Forcados GE, et al. Natural toxins and One Health: a review. Sci One Health. 2022;1: 100013. https://doi.org/10.1016/j.soh.2023.100013. · DOI
  64. Guerrant RL. Microbial toxins and diarrhoeal diseases: introduction and overview. Ciba Found Symp. 1985;112:1–13. https://doi.org/10.1002/9780470720936.ch1. · DOI
  65. Popoff MR. Overview of bacterial protein toxins from pathogenic bacteria: mode of action and insights into evolution. Toxins (Basel). 2024. https://doi.org/10.3390/toxins16040182. · DOI
  66. Moreira C, Azevedo J, Antunes A, Vasconcelos V. Cylindrospermopsin: occurrence, methods of detection and toxicology. J Appl Microbiol. 2013;114:605–20. https://doi.org/10.1111/jam.12048. · DOI
  67. Wang L, Zhang Q, Yan Z, Tan Y, Zhu R, Yu D, et al. Occurrence and quantitative risk assessment of twelve mycotoxins in eggs and chicken tissues in China. Toxins (Basel). 2018. https://doi.org/10.3390/toxins10110477. · DOI
  68. Sharma PC, Sharma D, Sharma A, Bhagat M, Ola M, Thakur VK, et al. Recent advances in microbial toxin-related strategies to combat cancer. Semin Cancer Biol. 2022;86:753–68. https://doi.org/10.1016/j.semcancer.2021.07.007. · DOI
  69. Pulingam T, Parumasivam T, Gazzali AM, Sulaiman AM, Chee JY, Lakshmanan M, et al. Antimicrobial resistance: prevalence, economic burden, mechanisms of resistance and strategies to overcome. Eur J Pharm Sci. 2022;170: 106103. https://doi.org/10.1016/j.ejps.2021.106103. · DOI
  70. Sulaiman SK, Musa MS, Tsiga-Ahmed FI, Dayyab FM, Sulaiman AK, Bako AT. A systematic review and meta-analysis of the prevalence of caregiver acceptance of malaria vaccine for under-five children in low-income and middle-income countries (LMICs). PLoS ONE. 2022;17: e0278224. https://doi.org/10.1371/journal.pone.0278224. · DOI
  71. Tsakou F, Jersie-Christensen R, Jenssen H, Mojsoska B. The role of proteomics in bacterial response to antibiotics. Pharmaceuticals (Basel). 2020. https://doi.org/10.3390/ph13090214. · DOI
  72. Zhang Q-Y, Yan Z-B, Meng Y-M, Hong X-Y, Shao G, Ma J-J, et al. Antimicrobial peptides: mechanism of action, activity and clinical potential. Mil Med Res. 2021;8:48. https://doi.org/10.1186/s40779-021-00343-2. · DOI
  73. Mohr KI, Volz C, Jansen R, Wray V, Hoffmann J, Bernecker S, et al. Pinensins: the first antifungal lantibiotics. Angew Chem Int Ed Engl. 2015;54:11254–8. https://doi.org/10.1002/anie.201500927. · DOI
  74. Arnison PG, Bibb MJ, Bierbaum G, Bowers AA, Bugni TS, Bulaj G, et al. Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep. 2013;30:108–60. https://doi.org/10.1039/c2np20085f. · DOI
  75. Montalbán-López M, Scott TA, Ramesh S, Rahman IR, van Heel AJ, Viel JH, et al. New developments in RiPP discovery, enzymology and engineering. Nat Prod Rep. 2021;38:130–239. https://doi.org/10.1039/d0np00027b. · DOI
  76. Süssmuth RD, Mainz A. Nonribosomal peptide synthesis-principles and prospects. Angew Chem Int Ed Engl. 2017;56:3770–821. https://doi.org/10.1002/anie.201609079. · DOI
  77. Chevallereau A, Pons BJ, van Houte S, Westra ER. Interactions between bacterial and phage communities in natural environments. Nat Rev Microbiol. 2022;20:49–62. https://doi.org/10.1038/s41579-021-00602-y. · DOI
  78. Cahill J, Young R. Phage lysis: multiple genes for multiple barriers. Adv Virus Res. 2019;103:33–70. https://doi.org/10.1016/bs.aivir.2018.09.003. · DOI
  79. Tkhilaishvili T, Lombardi L, Klatt A-B, Trampuz A, Di Luca M. Bacteriophage Sb-1 enhances antibiotic activity against biofilm, degrades exopolysaccharide matrix and targets persisters of Staphylococcus aureus. Int J Antimicrob Agents. 2018;52:842–53. https://doi.org/10.1016/j.ijantimicag.2018.09.006. · DOI
  80. Clokie MR, Millard AD, Letarov AV, Heaphy S. Phages in nature. Bacteriophage. 2011;1:31–45. https://doi.org/10.4161/bact.1.1.14942. · DOI
  81. Kim D, Hofstaedter CE, Zhao C, Mattei L, Tanes C, Clarke E, et al. Optimizing methods and dodging pitfalls in microbiome research. Microbiome. 2017;5:52. https://doi.org/10.1186/s40168-017-0267-5. · DOI
  82. Mirzayi C, Renson A, Furlanello C, Sansone S-A, Zohra F, Elsafoury S, et al. Reporting guidelines for human microbiome research: the STORMS checklist. Nat Med. 2021;27:1885–92. https://doi.org/10.1038/s41591-021-01552-x. · DOI
  83. Roume H, Heintz-Buschart A, Muller EEL, Wilmes P. Sequential isolation of metabolites, RNA, DNA, and proteins from the same unique sample. Methods Enzymol. 2013;531:219–36. https://doi.org/10.1016/B978-0-12-407863-5.00011-3. · DOI
  84. Deusch S, Seifert J. Catching the tip of the iceberg - evaluation of sample preparation protocols for metaproteomic studies of the rumen microbiota. Proteomics. 2015;15:3590–5. https://doi.org/10.1002/pmic.201400556. · DOI
  85. Heyer R, Kohrs F, Reichl U, Benndorf D. Metaproteomics of complex microbial communities in biogas plants. Microb Biotechnol. 2015;8:749–63. https://doi.org/10.1111/1751-7915.12276. · DOI
  86. Keiblinger KM, Fuchs S, Zechmeister-Boltenstern S, Riedel K. Soil and leaf litter metaproteomics-a brief guideline from sampling to understanding. FEMS Microbiol Ecol. 2016. https://doi.org/10.1093/femsec/fiw180. · DOI
  87. Kleikamp HBC, Grouzdev D, Schaasberg P, van Valderen R, van der Zwaan R, van Wijgaart R, de, et al. Metaproteomics, metagenomics and 16S rRNA sequencing provide different perspectives on the aerobic granular sludge microbiome. Water Res. 2023;246: 120700. https://doi.org/10.1016/j.watres.2023.120700. · DOI
  88. Kunath BJ, Minniti G, Skaugen M, Hagen LH, Vaaje-Kolstad G, Eijsink VGH, et al. Metaproteomics: sample preparation and methodological considerations. Adv Exp Med Biol. 2019;1073:187–215. https://doi.org/10.1007/978-3-030-12298-0_8. · DOI
  89. Speda J, Johansson MA, Carlsson U, Karlsson M. Assessment of sample preparation methods for metaproteomics of extracellular proteins. Anal Biochem. 2017;516:23–36. https://doi.org/10.1016/j.ab.2016.10.008. · DOI
  90. Zhang X, Li L, Mayne J, Ning Z, Stintzi A, Figeys D. Assessing the impact of protein extraction methods for human gut metaproteomics. J Proteomics. 2018;180:120–7. https://doi.org/10.1016/j.jprot.2017.07.001. · DOI
  91. Kohrs F, Heyer R, Magnussen A, Benndorf D, Muth T, Behne A, et al. Sample prefractionation with liquid isoelectric focusing enables in depth microbial metaproteome analysis of mesophilic and thermophilic biogas plants. Anaerobe. 2014;29:59–67. https://doi.org/10.1016/j.anaerobe.2013.11.009. · DOI
  92. Bumpus SB, Evans BS, Thomas PM, Ntai I, Kelleher NL. A proteomics approach to discovering natural products and their biosynthetic pathways. Nat Biotechnol. 2009;27:951–6. https://doi.org/10.1038/nbt.1565. · DOI
  93. Chen Y, Ntai I, Ju K-S, Unger M, Zamdborg L, Robinson SJ, et al. A proteomic survey of nonribosomal peptide and polyketide biosynthesis in actinobacteria. J Proteome Res. 2012;11:85–94. https://doi.org/10.1021/pr2009115. · DOI
  94. Meier JL, Burkart MD. Proteomic analysis of polyketide and nonribosomal peptide biosynthesis. Curr Opin Chem Biol. 2011;15:48–56. https://doi.org/10.1016/j.cbpa.2010.10.021. · DOI
  95. Dumas T, Martinez Pinna R, Lozano C, Radau S, Pible O, Grenga L, Armengaud J. The astounding exhaustiveness and speed of the Astral mass analyzer for highly complex samples is a quantum leap in the functional analysis of microbiomes. Microbiome. 2024;12:46. https://doi.org/10.1186/s40168-024-01766-4. · DOI
  96. Gómez-Varela D, Xian F, Grundtner S, Sondermann JR, Carta G, Schmidt M. Increasing taxonomic and functional characterization of host-microbiome interactions by DIA-PASEF metaproteomics. Front Microbiol. 2023;14: 1258703. https://doi.org/10.3389/fmicb.2023.1258703. · DOI
  97. Onigbinde S, Gutierrez Reyes CD, Sandilya V, Chukwubueze F, Oluokun O, Sahioun S, et al. Optimization of glycopeptide enrichment techniques for the identification of clinical biomarkers. Expert Rev Proteomics. 2024:1–32. https://doi.org/10.1080/14789450/2024.2418491. · DOI
  98. Armengaud J. Metaproteomics to understand how microbiota function: the crystal ball predicts a promising future. Environ Microbiol. 2023;25:115–25. https://doi.org/10.1111/1462-2920.16238. · DOI · Paper page
  99. von Bergen M, Jehmlich N, Taubert M, Vogt C, Bastida F, Herbst F-A, et al. Insights from quantitative metaproteomics and protein-stable isotope probing into microbial ecology. ISME J. 2013;7:1877–85. https://doi.org/10.1038/ismej.2013.78. · DOI
  100. Kleiner M, Kouris A, Violette M, D’Angelo G, Liu Y, Korenek A, et al. Ultra-sensitive isotope probing to quantify activity and substrate assimilation in microbiomes. Microbiome. 2023;11:24. https://doi.org/10.1186/s40168-022-01454-1. · DOI
  101. Starke R, Oliphant K, Jehmlich N, Schäpe SS, Sachsenberg T, Kohlbacher O, et al. Tracing incorporation of heavy water into proteins for species-specific metabolic activity in complex communities. J Proteomics. 2020;222: 103791. https://doi.org/10.1016/j.jprot.2020.103791. · DOI
  102. van Kasteren S, Rozen DE. Using click chemistry to study microbial ecology and evolution. ISME Commun. 2023;3:9. https://doi.org/10.1038/s43705-022-00205-5. · DOI
  103. Schaible GA, Jay ZJ, Cliff J, Schulz F, Gauvin C, Goudeau D, et al. Multicellular magnetotactic bacteria are genetically heterogeneous consortia with metabolically differentiated cells. PLoS Biol. 2024;22: e3002638. https://doi.org/10.1371/journal.pbio.3002638. · DOI
  104. Hellwig P, Dittrich A, Heyer R, Reichl U, Benndorf D. Detection, isolation and characterization of phage-host complexes using BONCAT and click chemistry. Front Microbiol. 2024;15: 1434301. https://doi.org/10.3389/fmicb.2024.1434301. · DOI
  105. Hellwig P, Kautzner D, Heyer R, Dittrich A, Wibberg D, Busche T, et al. Tracing active members in microbial communities by BONCAT and click chemistry-based enrichment of newly synthesized proteins. ISME Commun. 2024;4:ycae153. https://doi.org/10.1093/ismeco/ycae153. · DOI · Paper page
  106. Sanderlin AG, Kurka Margolis H, Meyer AF, Lamason RL. Cell-selective proteomics reveal novel effectors secreted by an obligate intracellular bacterial pathogen. Nat Commun. 2024;15:6073. https://doi.org/10.1038/s41467-024-50493-9. · DOI
  107. Schiebenhoefer H, Schallert K, Renard BY, Trappe K, Schmid E, Benndorf D, et al. A complete and flexible workflow for metaproteomics data analysis based on MetaProteomeAnalyzer and Prophane. Nat Protoc. 2020;15:3212–39. https://doi.org/10.1038/s41596-020-0368-7. · DOI
  108. Heyer R, Schallert K, Zoun R, Becher B, Saake G, Benndorf D. Challenges and perspectives of metaproteomic data analysis. J Biotechnol. 2017;261:24–36. https://doi.org/10.1016/j.jbiotec.2017.06.1201. · DOI
  109. Vande Moortele T, Devlaminck B, van de Vyver S, van den Bossche T, Martens L, Dawyndt P, et al. Unipept 6.0: Expanding metaproteomics analysis with support for missed cleavages, Semi-Tryptic and Non-Tryptic Peptides; 2024. · DOI
  110. Muth T, Behne A, Heyer R, Kohrs F, Benndorf D, Hoffmann M, et al. The MetaProteomeAnalyzer: a powerful open-source software suite for metaproteomics data analysis and interpretation. J Proteome Res. 2015;14:1557–65. https://doi.org/10.1021/pr501246w. · DOI
  111. Cheng K, Ning Z, Zhang X, Li L, Liao B, Mayne J, Figeys D. MetaLab 2.0 enables accurate post-translational modifications profiling in metaproteomics. J Am Soc Mass Spectrom. 2020;31:1473–82. https://doi.org/10.1021/jasms.0c00083. · DOI
  112. Medema MH, Blin K, Cimermancic P, de Jager V, Zakrzewski P, Fischbach MA, et al. antiSMASH: rapid identification, annotation and analysis of secondary metabolite biosynthesis gene clusters in bacterial and fungal genome sequences. Nucleic Acids Res. 2011;39:W339–46. https://doi.org/10.1093/nar/gkr466. · DOI
  113. Nesvizhskii AI. Proteogenomics: concepts, applications and computational strategies. Nat Methods. 2014;11:1114–25. https://doi.org/10.1038/nmeth.3144. · DOI
  114. van den Bossche T, Beslic D, van Puyenbroeck S, Suomi T, Holstein T, Martens L, et al. Metaproteomics beyond databases: addressing the challenges and potentials of de novo sequencing. Proteomics. 2025:e202400321. https://doi.org/10.1002/pmic.202400321. · DOI
  115. Bouwmeester R, Gabriels R, van den Bossche T, Martens L, Degroeve S. The age of data-driven proteomics: how machine learning enables novel workflows. Proteomics. 2020;20: e1900351. https://doi.org/10.1002/pmic.201900351. · DOI
  116. Lange E, Kranert L, Krüger J, Benndorf D, Heyer R. Microbiome modeling: a beginner’s guide. Front Microbiol. 2024;15: 1368377. https://doi.org/10.3389/fmicb.2024.1368377. · DOI · Paper page
  117. Priyadarsini M, Kushwaha J, Pandey KP, Rani J, Dhoble AS. Application of flow cytometry for rapid, high-throughput, multiparametric analysis of environmental microbiomes. J Microbiol Methods. 2023;214: 106841. https://doi.org/10.1016/j.mimet.2023.106841. · DOI
  118. Midani FS, David LA. Tracking defined microbial communities by multicolor flow cytometry reveals tradeoffs between productivity and diversity. Front Microbiol. 2022;13: 910390. https://doi.org/10.3389/fmicb.2022.910390. · DOI
  119. Anderson BG, Raskind A, Hissong R, Dougherty MK, McGill SK, Gulati AS, et al. Offline two-dimensional liquid chromatography-mass spectrometry for deep annotation of the fecal metabolome following fecal microbiota transplantation. J Proteome Res. 2024;23:2000–12. https://doi.org/10.1021/acs.jproteome.4c00022. · DOI
  120. Phillips M, Cataneo RN, Chaturvedi A, Kaplan PD, Libardoni M, Mundada M, et al. Detection of an extended human volatome with comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry. PLoS ONE. 2013;8: e75274. https://doi.org/10.1371/journal.pone.0075274. · DOI
  121. Walke D, Micheel D, Schallert K, Muth T, Broneske D, Saake G, Heyer R. The importance of graph databases and graph learning for clinical applications. Database (Oxford). 2023. https://doi.org/10.1093/database/baad045. · DOI
  122. Berry D, Widder S. Deciphering microbial interactions and detecting keystone species with co-occurrence networks. Front Microbiol. 2014;5: 219. https://doi.org/10.3389/fmicb.2014.00219. · DOI
  123. van den Bossche T, Kunath BJ, Schallert K, Schäpe SS, Abraham PE, Armengaud J, et al. Critical Assessment of MetaProteome Investigation (CAMPI): a multi-laboratory comparison of established workflows. Nat Commun. 2021;12:7305. https://doi.org/10.1038/s41467-021-27542-8. · DOI
  124. van Leeuwen PT, Brul S, Zhang J, Wortel MT. Synthetic microbial communities (SynComs) of the human gut: design, assembly, and applications. FEMS Microbiol Rev. 2023. https://doi.org/10.1093/femsre/fuad012. · DOI
  125. Banerjee S, Schlaeppi K, van der Heijden MGA. Keystone taxa as drivers of microbiome structure and functioning. Nat Rev Microbiol. 2018;16:567–76. https://doi.org/10.1038/s41579-018-0024-1. · DOI
  126. Herren CM, McMahon KD. Keystone taxa predict compositional change in microbial communities. Environ Microbiol. 2018;20:2207–17. https://doi.org/10.1111/1462-2920.14257. · DOI
  127. Li X-G, Chen M-X, Zhao S-Q, Wang X-Q. Intestinal models for personalized medicine: from conventional models to microfluidic primary intestine-on-a-chip. Stem Cell Rev Rep. 2022;18:2137–51. https://doi.org/10.1007/s12015-021-10205-y. · DOI
  128. Molly K, Vande Woestyne M, Verstraete W. Development of a 5-step multi-chamber reactor as a simulation of the human intestinal microbial ecosystem. Appl Microbiol Biotechnol. 1993;39:254–8. https://doi.org/10.1007/BF00228615. · DOI · Paper page
  129. Vorländer D, Schultz G, Hoffmann K, Rasch D, Dohnt K. PETR: a novel peristaltic mixed tubular bioreactor simulating human colonic conditions. Biotechnol Bioeng. 2024;121:1118–43. https://doi.org/10.1002/bit.28636. · DOI
  130. Shah P, Fritz JV, Glaab E, Desai MS, Greenhalgh K, Frachet A, et al. A microfluidics-based in vitro model of the gastrointestinal human–microbe interface. Nat Commun. 2016;7: 11535. https://doi.org/10.1038/ncomms11535. · DOI · Paper page
  131. Kunath BJ, Minniti G, Skaugen M, Hagen LH, Vaaje-Kolstad G, Eijsink VGH, et al. Metaproteomics: sample preparation and methodological considerations. In: Capelo-Martínez J-L, editor., et al., Emerging Sample Treatments in Proteomics. Cham: Springer International Publishing; 2019. p. 187–215. https://doi.org/10.1007/978-3-030-12298-0_8. · DOI
  132. Schiebenhoefer H, van den Bossche T, Fuchs S, Renard BY, Muth T, Martens L. Challenges and promise at the interface of metaproteomics and genomics: an overview of recent progress in metaproteogenomic data analysis. Expert Rev Proteomics. 2019;16:375–90. https://doi.org/10.1080/14789450.2019.1609944. · DOI
  133. Roume H, Muller EEL, Cordes T, Renaut J, Hiller K, Wilmes P. A biomolecular isolation framework for eco-systems biology. ISME J. 2013;7:110–21. https://doi.org/10.1038/ismej.2012.72. · DOI
  134. Heyer R, Schallert K, Büdel A, Zoun R, Dorl S, Behne A, et al. A robust and universal metaproteomics workflow for research studies and routine diagnostics within 24 h using phenol extraction, FASP digest, and the MetaProteomeAnalyzer. Front Microbiol. 2019;10: 1883. https://doi.org/10.3389/fmicb.2019.01883. · DOI
  135. Wang A, Fekete EEF, Creskey M, Cheng K, Ning Z, Pfeifle A, et al. Assessing fecal metaproteomics workflow and small protein recovery using DDA and DIA PASEF mass spectrometry. Microbiome Res Rep. 2024;3:39. https://doi.org/10.20517/mrr.2024.21. · DOI
  136. Tanca A, Schallert K, Grenga L, Peters SL, Abbondio M, Diego L de, et al. Critical Assessment of MetaProteome Investigation 2 (CAMPI-2): multi-laboratory assessment of sample processing methods to stabilize fecal microbiome for functional analysis; 2025. · DOI
  137. Lloréns-Rico V, Simcock JA, Huys GRB, Raes J. Single-cell approaches in human microbiome research. Cell. 2022;185:2725–38. https://doi.org/10.1016/j.cell.2022.06.040. · DOI
  138. Serrano-Villar S, Tincati C, Raju SC, Sáenz JS, Moreno E, Bargiela R, et al. Microbiome-derived cobalamin and succinyl-CoA as biomarkers for improved screening of anal cancer. Nat Med. 2023;29:1738–49. https://doi.org/10.1038/s41591-023-02407-3. · DOI
  139. Kunath BJ, de Rudder C, Laczny CC, Letellier E, Wilmes P. The oral-gut microbiome axis in health and disease. Nat Rev Microbiol. 2024;22:791–805. https://doi.org/10.1038/s41579-024-01075-5. · DOI
  140. Taneishi K, Tsuchiya Y. Structure-based analyses of gut microbiome-related proteins by neural networks and molecular dynamics simulations. Curr Opin Struct Biol. 2022;73: 102336. https://doi.org/10.1016/j.sbi.2022.102336. · DOI
  141. Pu Y, Li L, Peng H, Liu L, Heymann D, Robert C, et al. Drug-tolerant persister cells in cancer: the cutting edges and future directions. Nat Rev Clin Oncol. 2023;20:799–813. https://doi.org/10.1038/s41571-023-00815-5. · DOI
  142. Fossmark R, Olaisen M. Changes in the gastrointestinal microbiota induced by proton pump inhibitors-a review of findings from experimental trials. Microorganisms. 2024. https://doi.org/10.3390/microorganisms12061110. · DOI
  143. Sawaid IO, Samson AO. Proton pump inhibitors and cancer risk: a comprehensive review of epidemiological and mechanistic evidence. J Clin Med. 2024. https://doi.org/10.3390/jcm13071970. · DOI
  144. Aarnoutse R, Ziemons J, Penders J, Rensen SS, de Vos-Geelen J, Smidt ML. The clinical link between human intestinal microbiota and systemic cancer therapy. Int J Mol Sci. 2019. https://doi.org/10.3390/ijms20174145. · DOI
  145. Villéger R, Lopès A, Carrier G, Veziant J, Billard E, Barnich N, et al. Intestinal microbiota: a novel target to improve anti-tumor treatment? Int J Mol Sci. 2019. https://doi.org/10.3390/ijms20184584. · DOI
  146. Ervin SM, Ramanan SV, Bhatt AP. Relationship between the gut microbiome and systemic chemotherapy. Dig Dis Sci. 2020;65:874–84. https://doi.org/10.1007/s10620-020-06119-3. · DOI
  147. Chen J, Sun Y, Li J, Lyu M, Yuan L, Sun J, et al. In-depth metaproteomics analysis of tongue coating for gastric cancer: a multicenter diagnostic research study. Microbiome. 2024;12:6. https://doi.org/10.1186/s40168-023-01730-8. · DOI
  148. Cristobal-Cueto P, García-Quintanilla A, Esteban J, García-Quintanilla M. Phages in food industry biocontrol and bioremediation. Antibiotics (Basel). 2021. https://doi.org/10.3390/antibiotics10070786. · DOI
  149. Rocha I, Ma Y, Souza-Alonso P, Vosátka M, Freitas H, Oliveira RS. Seed coating: a tool for delivering beneficial microbes to agricultural crops. Front Plant Sci. 2019;10: 1357. https://doi.org/10.3389/fpls.2019.01357. · DOI
  150. Quinto EJ, Caro I, Villalobos-Delgado LH, Mateo J, De-Mateo-Silleras B, Redondo-Del-Río MP. Food safety through natural antimicrobials. Antibiotics (Basel) 2019. https://doi.org/10.3390/antibiotics8040208. · DOI
  151. Bhatt P, Engel BA, Reuhs M, Simsek H. Cyanophage technology in removal of cyanobacteria mediated harmful algal blooms: a novel and eco-friendly method. Chemosphere. 2023;315: 137769. https://doi.org/10.1016/j.chemosphere.2023.137769. · DOI
  152. Kumar M, Jaiswal S, Sodhi KK, Shree P, Singh DK, Agrawal PK, Shukla P. Antibiotics bioremediation: perspectives on its ecotoxicity and resistance. Environ Int. 2019;124:448–61. https://doi.org/10.1016/j.envint.2018.12.065. · DOI
  153. Liu M, Gill JJ, Young R, Summer EJ. Bacteriophages of wastewater foaming-associated filamentous Gordonia reduce host levels in raw activated sludge. Sci Rep. 2015;5: 13754. https://doi.org/10.1038/srep13754. · DOI
  154. Kim S-M, Heo HR, Kim CS, Shin HH. Genetically engineered bacteriophages as novel nanomaterials: applications beyond antimicrobial agents. Front Bioeng Biotechnol. 2024;12: 1319830. https://doi.org/10.3389/fbioe.2024.1319830. · DOI
  155. Qiu D, Ke M, Zhang Q, Zhang F, Lu T, Sun L, Qian H. Response of microbial antibiotic resistance to pesticides: an emerging health threat. Sci Total Environ. 2022;850: 158057. https://doi.org/10.1016/j.scitotenv.2022.158057. · DOI
  156. van Puyvelde B, Dhaenens M. Add mass spectrometry to the pandemic toolbox. Elife. 2021. https://doi.org/10.7554/eLife.75471. · DOI

Metadata

Authors
Heyer, R., Wolf, M., Benndorf, D., Uzzau, S., Seifert, J., Grenga, L., Pabst, M., Schmitt, H., Mesuere, B., Van Den Bossche, T., Haange, S.-B., Jehmlich, N., Di Luca, M., Ferrer, M., Serrano-Villar, S., Armengaud, J., Bode, H. B., Hellwig, P., Masselot, C. R., Léonard, R., & Wilmes, P.
Affiliations
  • Bielefeld University (DE)
  • Anhalt University of Applied Sciences (DE)
  • University of Sassari (IT)
  • University of Hohenheim (DE)
  • Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR)
  • Delft University of Technology (NL)
  • National Institute for Public Health and the Environment (NL)
  • Ghent University (BE)
  • Helmholtz Centre for Environmental Research (DE)
  • Consejo Superior de Investigaciones Científicas (ES)
  • Philipps University of Marburg (DE)
  • Max Planck Institute for Dynamics of Complex Technical Systems (DE)
  • Centre National de la Recherche Scientifique (FR)
  • University of Luxembourg (LU)
Corresponding author
Heyer, Robert
Venue
Microbiome
Published
2025-05-23
Volume
13
Issue
1
Pages
134-134
ISSN
2049-2618 (ISSN-L)
OpenAlex
W4410621645
Cited by
22
References
6
Citations by year
2026: 16 · 2025: 6
FWCI
5.51
Type
journal article
Language
en
Open access
Locations
  • Microbiome (publishedVersion, cc-by)
  • ChemRxiv (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (acceptedVersion)
  • Ghent University Academic Bibliography (Ghent University) (submittedVersion, cc-by)
  • Open Repository and Bibliography (University of Luxembourg) (submittedVersion, cc-by)
  • MPG.PuRe (Max Planck Society) (submittedVersion, other-oa)
  • HAL (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • UnissResearch (Università degli Studi di Sassari) (submittedVersion)
  • Publikationen an der Universität Bielefeld (Universität Bielefeld) (submittedVersion)
Funders
  • Région Occitanie (ANR-20-CE34-0012)
  • Agence Nationale de la Recherche (ANR-24-INBS-0015)
  • Research Foundation Flanders (1286824N)
  • Agencia Estatal de Investigación (MICIU/AEI/10.13039/501100011033)
  • NextGenerationEU/PRTR (PID2023-153370OB-I00)
  • CSIC (INMUNOBIOTA)
Topics
  • Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Phylogenetic Studies
Keywords
metaproteomics, One Health, microbiome, virulence factors, toxins, antibiotics, nonribosomal peptides, viruses, microbial interactions, microbiota modulation
MeSH terms
One Health, Animals, Bacteria, Humans, Virulence Factors, Proteomics, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review